Filing Details

Accession Number:
0000911916-20-000137
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-22 19:53:01
Reporting Period:
2020-06-22
Accepted Time:
2020-06-22 19:53:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
819050 Brickell Biotech Inc. BBI Biological Products, (No Disgnostic Substances) (2836) 930948554
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1782334 D Andrew Sklawer C/o Brickell Biotech, Inc.
5777 Central Avenue, Suite 102
Boulder CO 80301
Coo And Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-22 13,044 $0.00 96,250 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants (right to buy) Acquisiton 2020-06-22 13,044 $0.00 13,044 $1.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,044 2020-06-22 2025-06-22 No 4 P Direct
Footnotes
  1. The reported securities were purchased by the reporting person at a combined public offering price of $1.15 per share of common stock and accompanying warrant exercisable for one share of common stock.